The funding round will support the rapid development of single use flexible endoscopes and facilitate the company relocation to Wales.
"IQ Endoscopes disruptive technology eliminates the risk of cross contamination which is at the forefront of clinicians’ minds at the moment with the prevalence of COVID-19. Practitioners can’t risk contamination between endoscopy procedures. Creating a disposable endoscope, which is expected to be positioned at a lower cost point than current technology, is an extremely thrilling prospect and the reason why Creo Medical is keen to support the product development to get IQ Scope and platform to market as quickly as possible."
Turquoise backs carbon-negative mobility app SKOOT through the Low Carbon Innovation Fund 2.
"We were impressed by the SKOOT team who are already proven entrepreneurs. SKOOT has advantages of safety, cost, environmental impact and regulation compared with taxis. The platform is already built and robust and we see potential for large scale and international expansion of this innovative business."
The Series A round was backed by Episode 1, Playfair Capital, and Truesight Ventures, alongside an undisclosed lead investor.
"While talent is evenly distributed around the world, for too long, opportunities have not been. I have experienced first hand the challenge of hiring globally. When I was a CEO attempting to grow a team across different jurisdictions I was dismayed by the baroque complexity and lack of affordable tech-driven solutions."
Smedvig Capital led the Series A round with participation from Guy Hands and 24 Haymarket.
"This funding round will facilitate our strategic objective of being a leading primary research platform for the private equity and consulting sectors."
